To clarify.
My use of the words "in theory" relates to the actual broader goal of the business itself. That you can, from a small donor base, build a business that markets a variety of theraputic products. That is, as yet, simply not known, as it has not occured. It's never been open to "theroetical question", that CYP's technology could do "theoretically", what they desired it to do - otherwise they would not have bought into it - independent clinical proof was required, by the regulators, to take the technology forward in to human trials.
To clarify. My use of the words "in theory" relates to the...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
91.5¢ |
Change
0.010(1.10%) |
Mkt cap ! $1.044B | |||
| Open | High | Low | Value | Volume |
| 93.0¢ | 93.5¢ | 90.5¢ | $4.638M | 5.036M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 152669 | 91.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 51069 | 3 |
View Market Depth
| Last trade - 16.10pm 07/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |